The F.D.A. could grant full approval to Pfizer’s vaccine by early September.
By Sharon LaFraniere and Noah Weiland
Read the full article from The New York Times, here.
With a surge of Covid-19 infections ripping through much of the United States, the Food and Drug Administration has accelerated its timetable to fully approve the Pfizer-BioNTech coronavirus vaccine, aiming to complete the process by the start of next month, people familiar with the effort said.
President Biden said last week that he expected a fully approved vaccine in early fall. But the F.D.A.’s unofficial deadline is Labor Day or sooner, according to several people familiar with the plan. The agency said in a statement that its leaders recognized that approval might increase public confidence and had “taken an all-hands-on-deck approach” to the work.